Bone Biologics (BBLG) Expected to Announce Earnings on Wednesday

Bone Biologics (NASDAQ:BBLG) will likely be announcing its earnings results before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of ($0.65) per share for the quarter.

Bone Biologics Stock Down 1.0 %

Shares of NASDAQ:BBLG opened at $1.02 on Wednesday. The business has a 50-day moving average of $1.06 and a two-hundred day moving average of $1.41. Bone Biologics has a fifty-two week low of $0.80 and a fifty-two week high of $4.49.

About Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.